Transcat Inc

Transcat, Inc. (TRNS) provides calibration and testing services to highly regulated industries. The stock gained over +29%, supported by solid fundamentals and a return to more normalized organic growth. Investors were encouraged by the combination of steady execution, recurring revenue characteristics, and exposure to resilient end markets such as life sciences and aerospace. The more important signal was improving underlying demand and customer activity, with service organic revenue growth returning to 7%.

Transcat, Inc. (TRNS) has built an impressive distribution and service platform serving the healthcare sector. We believe trends are poised to accelerate as uncertainty in customer demand during 2025 gives way to a more favorable outlook in 2026. Major pharmaceutical and healthcare supply chain companies have announced significant capex projects, and the push to reshore production remains a government and corporate priority. As production moves onshore, we believe TRNS will see expanding growth opportunities. The company’s scale and strong reputation give it a competitive advantage in winning business from smaller players. We believe this relatively underfollowed stock will surprise to the upside as hundreds of billions in incremental investments materialize over the next few years.

Transcat delivered a disappointing quarter primarily due to the underperformance of their 2021 Nexa acquisition. However, the core calibration business continues to perform well, and the critical nature of Transcat’s services, along with the trend toward outsourcing and ample M&A opportunities, supports a long-term bullish thesis. Management has ring-fenced the issues from the Nexa acquisition, indicating confidence in the core business's resilience and growth potential.

Transcat delivered a disappointing quarter primarily due to the underperformance of their 2021 Nexa acquisition. However, the core calibration business continues to perform well, and the critical nature of Transcat’s services, along with the trend toward outsourcing and ample M&A opportunities, supports a long-term bullish thesis. Management has ring-fenced the issues from Nexa, indicating confidence in the core business's resilience and growth potential.